From: Serum zinc levels and in vivo beta-amyloid deposition in the human brain
Characteristic | Overall | Categorized zinc level | P | ||
---|---|---|---|---|---|
Low | Medium | High | |||
N | 241 | 70 | 80 | 91 | |
Age, y | 69.73 (8.00) | 70.14 (7.13) | 71.04 (8.41) | 68.26 (8.11) | 0.067a |
Female, n (%) | 114 (47.30) | 36 (51.43) | 39 (48.75) | 39 (42.86) | 0.531b |
Education, y | 11.61 (4.76) | 11.00 (4.84) | 11.39 (4.92) | 12.27 (4.50) | 0.212a |
APOE4 positivity, n (%) | 44 (18.26) | 14 (20.00) | 15 (18.75) | 15 (16.48) | 0.841b |
VRS, % | 17.57 (16.47) | 16.90 (14.33) | 18.54 (17.18) | 17.22 (17.47) | 0.806a |
MMSE | 26.82 (2.67) | 26.34 (2.44) | 26. 93 (3.29) | 27.10 (2.18) | 0.189a |
BMI, kg/m2 | 24.18 (2.92) | 24.29 (3.06) | 24.00 (2.80) | 24.25 (2.94) | 0.793a |
GDS score | 4.93 (5.09) | 5.04 (5.24) | 5.63 (5.26) | 4.22 (4.76) | 0.192a |
Annual income status | 0.887c | ||||
< MCL, n (%) | 15 (6.22) | 3 (4.29) | 5 (6.25) | 7 (7.69) | |
≥MCL, < 2 × MCL, n (%) | 115 (47.72) | 32 (45.71) | 40 (50.00) | 43 (47.25) | |
≥2 × MCL, n (%) | 111 (46.06) | 35 (50.00) | 35 (43.75) | 41 (45.05) | |
Zinc, μg/dL | 86.85 (11.79) | 73.36 (4.90) | 85.04 (2.85) | 98.80 (7.50) | < 0.001a |
Albumin, g/dL | 4.49 (0.25) | 4.38 (0.23) | 4.53 (0.21) | 4.53 (0.27) | < 0.001a |
Copper, μg/dL | 102.32 (17.78) | 100.73 (20.25) | 101.91 (15.62) | 103.91 (17.60) | 0.515a |
Calcium, mg/dL | 9.45 (0.31) | 9.35 (0.30) | 9.46 (0.29) | 9.50 (0.32) | 0.010a |
Iron, μg/dL | 122.61 (40.75) | 111.59 (41.13) | 116.84 (38.35) | 136.18 (39.13) | < 0.001a |
Transferrin, mg/dL | 271.15 (39.38) | 262.74 (37.04) | 271.26 (38.67) | 277.51 (40.92) | 0.061a |
Ceruloplasmin, mg/dL | 24.14 (5.08) | 23.91 (5.78) | 24.87 (4.41) | 23.67 (5.04) | 0.276a |
Total cholesterol, mg/dL | 183.57 (31.49) | 181.50 (27.66) | 180.75 (28.86) | 187.64 (36.05) | 0.293a |
Nutritional deficiency | 36 (14.94) | 10 (14.29) | 13 (16.25) | 13 (14.29) | 0.922b |
Neuroimage biomarkers | |||||
Cerebral Aβ deposition | |||||
Aβ retention, SUVR | 1.20 (0.23) | 1.26 (0.34) | 1.20 (0.21) | 1.16 (0.12) | 0.021a |
Cerebral tau deposition (n = 58) | |||||
AV-1451, SUVR | 1.34 (0.26) | 1.36 (0.30) | 1.29 (0.21) | 1.38 (0.24) | 0.575a |
AD-CM, SUVR | 1.42 (0.12) | 1.39 (0.13) | 1.41 (0.12) | 1.44 (0.12) | 0.077a |
WMH volume, cm3 | 12.29 (11.68) | 11.14 (10.13) | 12.91 (12.37) | 12.65 (12.25) | 0.625a |